Rucaparib

Category: Cancer



Rucaparib Overview

Rucaparib (brand name Rubraca /rubrk/ roo-BRAH-k) is a PARP inhibitor used as an anti-cancer agent. Rucaparib is a first-in-class pharmaceutical drug targeting the DNA repair enzyme poly-ADP ribose polymerase-1 (PARP-1). It is approved in the United States and in Europe as third line treatment in BRCA-mutated ovarian cancer.[2][3][4] It can be taken orally in tablet form.[1][5] Contents 1 Development 2 Pharmaco...

Read more Rucaparib Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Rucaparib

Recent Rucaparib Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Rucaparib
  • Tablet: 200mg, 250mg, 300mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Other drugs which contain Rucaparib or a similar ingredient: (1 result)




Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 14 August 2020.

We are committed to your privacy.

Copyright © 2005-2020 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA